Andrew Welsch

Net income and client assets grew even as the firms' headcount continued its steady decline.

The moves are intended to boost the firm's capital markets abilities in a changing interest rate environment.

The elite brokerage unit picked up three veteran advisers, On Wall Street reports exclusively.

A team joined the wirehouse from Wells Fargo Private Bank.

The boutique wealth management firm picked up three industry veterans from two smaller rivals.

The wirehouse aims to grow its adviser ranks in a potential bid to surpass its larger rival Morgan Stanley, according to Andy Sieg, head of Merrill Lynch.

One brokerage executive likens the situation to changing the rules of a football game after the teams are already on the field.

The firm's latest hire is an industry veteran of more than two decades.

The firm's latest hire has nearly three decades of industry experience.

The Labor Department will now conduct a review with an eye toward amending or rescinding it.

William Blake, the independent firm's 10th hire this year, says he was attracted by the chance to become a partner.

The new hires joined the wirehouse from J.P. Morgan Securities, On Wall Street learns exclusively.

Several division executives have moved into new roles, retired or left the company, according to a memo seen by On Wall Street.

Wirehouse and regional advisers can help honor the industry's top leaders.

A federal judge ruled that the ex-Barclays advisor had been unfairly forced into FINRA arbitration, where a panel had ruled against him.

Big firms are asking for more time, while investors and even some advisers are asking the Labor Department to keep the rule intact.

A higher standard of client care can still be enforced in the marketplace, fiduciary supporters say.

The ex-Morgan Stanley advisers say their niche practice, which is geared toward women and divorcees, will be better supported by Raymond James' platform.

The group previously worked at Merrill Lynch, where they generated over $2 million in annual revenue.

The former adviser allegedly pocketed more than $300,000 from trades involving pharmaceutical stocks.